Autonomous Medical Devices Incorporated (AMDI) today announced that the U.S. Food and Drug Administration has granted both ...

Because of its high accuracy, laboratory-based polymerase chain reaction (PCR) testing is the gold standard for infectious disease diagnostics. However, PCR technology requires highly trained staff ...

Over the past four years, many of us have become accustomed to a swab up the nose to test for COVID-19, using at-home rapid antigen tests or the more accurate clinic-provided PCR tests with a longer ...

The COVID-19 pandemic yielded important advances in testing for respiratory viruses, but it also exposed important unmet needs in screening to prevent the spread of infections in high-risk settings.

According to WHO, it can be difficult to clinically distinguish Ebola disease from other infectious diseases such as malaria, typhoid fever, shigellosis, meningitis and other viral haemorrhagic fevers ...

The question quickly arose whether existing rapid antigen tests could detect newly emerging variants. Using clinical samples obtained from diagnostic labs throughout the U.S. from 2020 to 2023, the ...

A new biotechnology company in McKinney has ambitions to become the world's first fully integrated platform for polymerase chain reaction (PCR) testing - the same technology behind a common COVID-19 ...

Northwestern scientists have created the fastest-ever hepatitis C diagnostic, delivering accurate results in only 15 minutes. The test uses the DASH rapid PCR system, originally developed for COVID, ...